Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Dan E. Arking is active.

Publication


Featured researches published by Dan E. Arking.


The New England Journal of Medicine | 2008

Association between Microdeletion and Microduplication at 16p11.2 and Autism

Lauren A. Weiss; Yiping Shen; Joshua M. Korn; Dan E. Arking; David T. Miller; Ragnheidur Fossdal; Evald Saemundsen; Hreinn Stefansson; Todd Green; Orah S. Platt; Douglas M. Ruderfer; Christopher A. Walsh; David Altshuler; Aravinda Chakravarti; Rudolph E. Tanzi; Kari Stefansson; Susan L. Santangelo; James F. Gusella; Pamela Sklar; Bai-Lin Wu; Mark J. Daly

BACKGROUND Autism spectrum disorder is a heritable developmental disorder in which chromosomal abnormalities are thought to play a role. METHODS As a first component of a genomewide association study of families from the Autism Genetic Resource Exchange (AGRE), we used two novel algorithms to search for recurrent copy-number variations in genotype data from 751 multiplex families with autism. Specific recurrent de novo events were further evaluated in clinical-testing data from Childrens Hospital Boston and in a large population study in Iceland. RESULTS Among the AGRE families, we observed five instances of a de novo deletion of 593 kb on chromosome 16p11.2. Using comparative genomic hybridization, we observed the identical deletion in 5 of 512 children referred to Childrens Hospital Boston for developmental delay, mental retardation, or suspected autism spectrum disorder, as well as in 3 of 299 persons with autism in an Icelandic population; the deletion was also carried by 2 of 18,834 unscreened Icelandic control subjects. The reciprocal duplication of this region occurred in 7 affected persons in AGRE families and 4 of the 512 children from Childrens Hospital Boston. The duplication also appeared to be a high-penetrance risk factor. CONCLUSIONS We have identified a novel, recurrent microdeletion and a reciprocal microduplication that carry substantial susceptibility to autism and appear to account for approximately 1% of cases. We did not identify other regions with similar aggregations of large de novo mutations.


Nature Genetics | 2003

Dysregulation of TGF-β activation contributes to pathogenesis in Marfan syndrome

Enid R. Neptune; Pamela A. Frischmeyer; Dan E. Arking; Loretha Myers; Tracie E. Bunton; Barbara Gayraud; Francesco Ramirez; Lynn Y. Sakai; Harry C. Dietz

Marfan syndrome is an autosomal dominant disorder of connective tissue caused by mutations in fibrillin-1 (encoded by FBN1 in humans and Fbn1 in mice), a matrix component of extracellular microfibrils. A distinct subgroup of individuals with Marfan syndrome have distal airspace enlargement, historically described as emphysema, which frequently results in spontaneous lung rupture (pneumothorax; refs. 1–3). To investigate the pathogenesis of genetically imposed emphysema, we analyzed the lung phenotype of mice deficient in fibrillin-1, an accepted model of Marfan syndrome. Lung abnormalities are evident in the immediate postnatal period and manifest as a developmental impairment of distal alveolar septation. Aged mice deficient in fibrillin-1 develop destructive emphysema consistent with the view that early developmental perturbations can predispose to late-onset, seemingly acquired phenotypes. We show that mice deficient in fibrillin-1 have marked dysregulation of transforming growth factor-β (TGF-β) activation and signaling, resulting in apoptosis in the developing lung. Perinatal antagonism of TGF-β attenuates apoptosis and rescues alveolar septation in vivo. These data indicate that matrix sequestration of cytokines is crucial to their regulated activation and signaling and that perturbation of this function can contribute to the pathogenesis of disease.


Nature Genetics | 2009

Genome-wide association study of blood pressure and hypertension

Daniel Levy; Georg B. Ehret; Kenneth Rice; Germaine C. Verwoert; Lenore J. Launer; Abbas Dehghan; Nicole L. Glazer; Alanna C. Morrison; Andrew D. Johnson; Thor Aspelund; Yurii S. Aulchenko; Thomas Lumley; Anna Köttgen; Fernando Rivadeneira; Gudny Eiriksdottir; Xiuqing Guo; Dan E. Arking; Gary F. Mitchell; Francesco Mattace-Raso; Albert V. Smith; Kent D. Taylor; Robert B. Scharpf; Shih Jen Hwang; Eric J.G. Sijbrands; Joshua C. Bis; Tamara B. Harris; Santhi K. Ganesh; Christopher J. O'Donnell; Albert Hofman; Jerome I. Rotter

Blood pressure is a major cardiovascular disease risk factor. To date, few variants associated with interindividual blood pressure variation have been identified and replicated. Here we report results of a genome-wide association study of systolic (SBP) and diastolic (DBP) blood pressure and hypertension in the CHARGE Consortium (n = 29,136), identifying 13 SNPs for SBP, 20 for DBP and 10 for hypertension at P < 4 × 10−7. The top ten loci for SBP and DBP were incorporated into a risk score; mean BP and prevalence of hypertension increased in relation to the number of risk alleles carried. When ten CHARGE SNPs for each trait were included in a joint meta-analysis with the Global BPgen Consortium (n = 34,433), four CHARGE loci attained genome-wide significance (P < 5 × 10−8) for SBP (ATP2B1, CYP17A1, PLEKHA7, SH2B3), six for DBP (ATP2B1, CACNB2, CSK-ULK3, SH2B3, TBX3-TBX5, ULK4) and one for hypertension (ATP2B1). Identifying genes associated with blood pressure advances our understanding of blood pressure regulation and highlights potential drug targets for the prevention or treatment of hypertension.


Nature Genetics | 2005

Genomic alterations in cultured human embryonic stem cells

Anirban Maitra; Dan E. Arking; Narayan Shivapurkar; Morna Ikeda; Victor Stastny; Keyaunoosh Kassauei; Guoping Sui; David J. Cutler; Ying Liu; Sandii N. Brimble; Karin Noaksson; Johan Hyllner; Thomas C. Schulz; Xianmin Zeng; William J. Freed; Jeremy M. Crook; Suman Abraham; Alan Colman; Peter Sartipy; Sei Ichi Matsui; Melissa K. Carpenter; Adi F. Gazdar; Mahendra S. Rao; Aravinda Chakravarti

Cultured human embryonic stem cell (hESC) lines are an invaluable resource because they provide a uniform and stable genetic system for functional analyses and therapeutic applications. Nevertheless, these dividing cells, like other cells, probably undergo spontaneous mutation at a rate of 10−9 per nucleotide. Because each mutant has only a few progeny, the overall biological properties of the cell culture are not altered unless a mutation provides a survival or growth advantage. Clonal evolution that leads to emergence of a dominant mutant genotype may potentially affect cellular phenotype as well. We assessed the genomic fidelity of paired early- and late-passage hESC lines in the course of tissue culture. Relative to early-passage lines, eight of nine late-passage hESC lines had one or more genomic alterations commonly observed in human cancers, including aberrations in copy number (45%), mitochondrial DNA sequence (22%) and gene promoter methylation (90%), although the latter was essentially restricted to 2 of 14 promoters examined. The observation that hESC lines maintained in vitro develop genetic and epigenetic alterations implies that periodic monitoring of these lines will be required before they are used in in vivo applications and that some late-passage hESC lines may be unusable for therapeutic purposes.


American Journal of Human Genetics | 2008

A Common Genetic Variant in the Neurexin Superfamily Member CNTNAP2 Increases Familial Risk of Autism

Dan E. Arking; David J. Cutler; Camille W. Brune; Tanya M. Teslovich; Kristen West; Morna Ikeda; Alexis Rea; Moltu Guy; Shin Lin; Edwin H. Cook; Aravinda Chakravarti

Autism is a childhood neuropsychiatric disorder that, despite exhibiting high heritability, has largely eluded efforts to identify specific genetic variants underlying its etiology. We performed a two-stage genetic study in which genome-wide linkage and family-based association mapping was followed up by association and replication studies in an independent sample. We identified a common polymorphism in contactin-associated protein-like 2 (CNTNAP2), a member of the neurexin superfamily, that is significantly associated with autism susceptibility. Importantly, the genetic variant displays a parent-of-origin and gender effect recapitulating the inheritance of autism.


Nature Genetics | 2006

A common genetic variant in the NOS1 regulator NOS1AP modulates cardiac repolarization

Dan E. Arking; Arne Pfeufer; Wendy S. Post; W.H. Linda Kao; Christopher Newton-Cheh; Morna Ikeda; Kristen West; Carl S. Kashuk; Mahmut Akyol; Siegfried Perz; Shapour Jalilzadeh; Thomas Illig; Christian Gieger; Chao Yu Guo; Martin G. Larson; H.-Erich Wichmann; Eduardo Marban; Christopher J. O'Donnell; Joel N. Hirschhorn; Stefan Kääb; Peter M. Spooner; Thomas Meitinger; Aravinda Chakravarti

Extremes of the electrocardiographic QT interval, a measure of cardiac repolarization, are associated with increased cardiovascular mortality. We identified a common genetic variant influencing this quantitative trait through a genome-wide association study on 200 subjects at the extremes of a population-based QT interval distribution of 3,966 subjects from the KORA cohort in Germany, with follow-up screening of selected markers in the remainder of the cohort. We validated statistically significant findings in two independent samples of 2,646 subjects from Germany and 1,805 subjects from the US Framingham Heart Study. This genome-wide study identified NOS1AP (CAPON), a regulator of neuronal nitric oxide synthase, as a new target that modulates cardiac repolarization. Approximately 60% of subjects of European ancestry carry at least one minor allele of the NOS1AP genetic variant, which explains up to 1.5% of QT interval variation.


Nature Genetics | 2009

Multiple loci associated with indices of renal function and chronic kidney disease

Anna Köttgen; Nicole L. Glazer; Abbas Dehghan; Shih Jen Hwang; Ronit Katz; Man Li; Qiong Yang; Vilmundur Gudnason; Lenore J. Launer; Tamara B. Harris; Albert V. Smith; Dan E. Arking; Brad C. Astor; Eric Boerwinkle; Georg B. Ehret; Ingo Ruczinski; Robert B. Scharpf; Yii-Der I. Chen; Ian H. de Boer; Talin Haritunians; Thomas Lumley; Mark J. Sarnak; David S. Siscovick; Emelia J. Benjamin; Daniel Levy; Ashish Upadhyay; Yurii S. Aulchenko; Albert Hofman; Fernando Rivadeneira; Andre G. Uitterlinden

Chronic kidney disease (CKD) has a heritable component and is an important global public health problem because of its high prevalence and morbidity. We conducted genome-wide association studies (GWAS) to identify susceptibility loci for glomerular filtration rate, estimated by serum creatinine (eGFRcrea) and cystatin C (eGFRcys), and CKD (eGFRcrea < 60 ml/min/1.73 m2) in European-ancestry participants of four population-based cohorts (ARIC, CHS, FHS, RS; n = 19,877; 2,388 CKD cases), and tested for replication in 21,466 participants (1,932 CKD cases). We identified significant SNP associations (P < 5 × 10−8) with CKD at the UMOD locus, with eGFRcrea at UMOD, SHROOM3 and GATM-SPATA5L1, and with eGFRcys at CST and STC1. UMOD encodes the most common protein in human urine, Tamm-Horsfall protein, and rare mutations in UMOD cause mendelian forms of kidney disease. Our findings provide new insights into CKD pathogenesis and underscore the importance of common genetic variants influencing renal function and disease.


Nature Genetics | 2010

Common variants in KCNN3 are associated with lone atrial fibrillation

Patrick T. Ellinor; Kathryn L. Lunetta; Nicole L. Glazer; Arne Pfeufer; Alvaro Alonso; Mina K. Chung; Moritz F. Sinner; Paul I. W. de Bakker; Martina Mueller; Steven A. Lubitz; Ervin R. Fox; Dawood Darbar; Nicholas L. Smith; Jonathan D. Smith; Renate B. Schnabel; Elsayed Z. Soliman; Kenneth Rice; David R. Van Wagoner; Britt-M. Beckmann; Charlotte van Noord; Ke Wang; Georg Ehret; Jerome I. Rotter; Stanley L. Hazen; Gerhard Steinbeck; Albert V. Smith; Lenore J. Launer; Tamara B. Harris; Seiko Makino; Mari Nelis

Atrial fibrillation (AF) is the most common sustained arrhythmia. Previous studies have identified several genetic loci associated with typical AF. We sought to identify common genetic variants underlying lone AF. This condition affects a subset of individuals without overt heart disease and with an increased heritability of AF. We report a meta-analysis of genome-wide association studies conducted using 1,335 individuals with lone AF (cases) and 12,844 unaffected individuals (referents). Cases were obtained from the German AF Network, Heart and Vascular Health Study, the Atherosclerosis Risk in Communities Study, the Cleveland Clinic and Massachusetts General Hospital. We identified an association on chromosome 1q21 to lone AF (rs13376333, adjusted odds ratio = 1.56; P = 6.3 × 10−12), and we replicated this association in two independent cohorts with lone AF (overall combined odds ratio = 1.52, 95% CI 1.40–1.64; P = 1.83 × 10−21). rs13376333 is intronic to KCNN3, which encodes a potassium channel protein involved in atrial repolarization.


Nature Genetics | 2012

Meta-analysis identifies six new susceptibility loci for atrial fibrillation

Patrick T. Ellinor; Kathryn L. Lunetta; Christine M. Albert; Nicole L. Glazer; Marylyn D. Ritchie; Albert V. Smith; Dan E. Arking; Martina Müller-Nurasyid; Bouwe P. Krijthe; Steven A. Lubitz; Joshua C. Bis; Mina K. Chung; Marcus Dörr; Kouichi Ozaki; Jason D. Roberts; J. Gustav Smith; Arne Pfeufer; Moritz F. Sinner; Kurt Lohman; Jingzhong Ding; Nicholas L. Smith; Jonathan D. Smith; Michiel Rienstra; Kenneth Rice; David R. Van Wagoner; Jared W. Magnani; Reza Wakili; Sebastian Clauss; Jerome I. Rotter; Gerhard Steinbeck

Atrial fibrillation is a highly prevalent arrhythmia and a major risk factor for stroke, heart failure and death. We conducted a genome-wide association study (GWAS) in individuals of European ancestry, including 6,707 with and 52,426 without atrial fibrillation. Six new atrial fibrillation susceptibility loci were identified and replicated in an additional sample of individuals of European ancestry, including 5,381 subjects with and 10,030 subjects without atrial fibrillation (P < 5 × 10−8). Four of the loci identified in Europeans were further replicated in silico in a GWAS of Japanese individuals, including 843 individuals with and 3,350 individuals without atrial fibrillation. The identified loci implicate candidate genes that encode transcription factors related to cardiopulmonary development, cardiac-expressed ion channels and cell signaling molecules.


Nature Genetics | 2009

Common variants at ten loci modulate the QT interval duration in the QTSCD Study

Arne Pfeufer; Serena Sanna; Dan E. Arking; Martina Müller; Vesela Gateva; Christian Fuchsberger; Georg B. Ehret; Marco Orru; Cristian Pattaro; Anna Köttgen; Siegfried Perz; Gianluca Usala; Maja Barbalic; Man Li; Benno Pütz; Angelo Scuteri; Ronald J. Prineas; Moritz F. Sinner; Christian Gieger; Samer S. Najjar; W.H. Linda Kao; Thomas W. Mühleisen; Mariano Dei; Christine Happle; Stefan Möhlenkamp; Laura Crisponi; Raimund Erbel; Karl-Heinz Jöckel; Silvia Naitza; Gerhard Steinbeck

The QT interval, a measure of cardiac repolarization, predisposes to ventricular arrhythmias and sudden cardiac death (SCD) when prolonged or shortened. A common variant in NOS1AP is known to influence repolarization. We analyze genome-wide data from five population-based cohorts (ARIC, KORA, SardiNIA, GenNOVA and HNR) with a total of 15,842 individuals of European ancestry, to confirm the NOS1AP association and identify nine additional loci at P < 5 × 10−8. Four loci map near the monogenic long-QT syndrome genes KCNQ1, KCNH2, SCN5A and KCNJ2. Two other loci include ATP1B1 and PLN, genes with established electrophysiological function, whereas three map to RNF207, near LITAF and within NDRG4-GINS3-SETD6-CNOT1, respectively, all of which have not previously been implicated in cardiac electrophysiology. These results, together with an accompanying paper from the QTGEN consortium, identify new candidate genes for ventricular arrhythmias and SCD.

Collaboration


Dive into the Dan E. Arking's collaboration.

Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Eric Boerwinkle

University of Texas Health Science Center at Houston

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Joshua C. Bis

University of Washington

View shared research outputs
Researchain Logo
Decentralizing Knowledge